Please assess the completion status of the following clinical trial:

Trial Title: Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Outpatients who are required a combination therapy with sitting systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg.~* Outpatients aged over 40 years and less than 85 years (inclusive), regardless of sex.~* Previously untreated patients or patients who are on other therapy, which can be converted to 4mg of benidipine.~* Patients who can be treated with benidipine, angiotensin receptor blockers, β-blockers, and thiazide diuretics.~Exclusion Criteria:~* Seated systolic blood pressure ≥ 200 mmHg or seated diastolic blood pressure ≥ 120 mmHg.~* Secondary hypertension.~* Type I diabetes mellitus or type 2 diabetes on insulin treatment.~* History of cerebrovascular disorder, myocardial infarction, angina pectoris, coronary angioplasty or coronary artery bypass graft surgery within 6 months prior to enrolment in the study.~* Heart failure (New York Heart Association \[NYHA\] functional classification II, III or IV).~* Chronic atrial fibrillation or atrial flutter.~* Congenital heart disease or a history of rheumatic heart disease.~* Severe peripheral arterial disease (Fontaine Class II, III or IV).~* Serious liver dysfunction (AST or ALT ≥100 IU / l).~* Serious renal dysfunction (serum creatinine ≥ 2mg/dl).~* History of malignancy 5 years prior to study entry.~* Pregnancy.~* Compliance rate \< 70% assessed by a patient interview.~* Known hypersensitivity or contraindication to benidipine, angiotensin receptor blockers, β-blockers, and thiazide diuretics.~* Other serious illness or significant abnormalities that the investigator judges inappropriate for the study

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- angiotensin receptor blockers (Type: ACTIVE_COMPARATOR): benidipine+angiotensin receptor blockers, titlation scheme
- β-blockers (Type: ACTIVE_COMPARATOR): benidipie+β-blockers, titlation scheme
- thiazide diuretics (Type: ACTIVE_COMPARATOR): benidipine+thiazide diuretics, titlation scheme

Based on this trial design, predict the completion outcome and termination type (if applicable).